Maccalid Misquith
⚠️ High Risk
FEI: 3007480327 • Chennai, Tamil Nadu • INDIA
FEI Number
3007480327
Location
Chennai, Tamil Nadu
Country
INDIAAddress
31 Jagnathan Colony Foxen St, , Chennai, Tamil Nadu, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/23/2009 | 56DCY41NEOMYCIN SULFATE (AMINOGLYCOSIDES) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 62ODA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 62GDA99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 56YDY99ANTIBIOTIC N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 60LCA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 62CAA99ANTI-HYPERTENSIVE N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 61PCB26METFORMIN (ANTI-DIABETIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 56BCB03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 61JCB99ANTI-CHOLESTEREMIC, N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 62OCB22CARVEDILOL (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 62OCA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/23/2009 | 60LCA05ASPIRIN (ANALGESIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Maccalid Misquith's FDA import refusal history?
Maccalid Misquith (FEI: 3007480327) has 12 FDA import refusal record(s) in our database, spanning from 4/23/2009 to 4/23/2009.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Maccalid Misquith's FEI number is 3007480327.
What types of violations has Maccalid Misquith received?
Maccalid Misquith has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Maccalid Misquith come from?
All FDA import refusal data for Maccalid Misquith is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.